Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Albiglutide clinical trials
2 selected ClinicalTrials.gov records carrying the official matched intervention Albiglutide (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
2 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 4 selected PubMed records and 1 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT01777282
PeptideScanner retained ClinicalTrials.gov record NCT01777282 at 2026-11-16T17:45:42.793Z. Its registry update date was 2017-05-03, and PeptideScanner's reviewed identity mapping was albiglutide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- May 3, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT02229227
PeptideScanner retained ClinicalTrials.gov record NCT02229227 at 2026-11-16T17:45:42.793Z. Its registry update date was 2020-11-27, and PeptideScanner's reviewed identity mapping was albiglutide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- November 27, 2020
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Albiglutide · 2020-11-27
ClinicalTrials.gov record NCT02229227
Completed at the retained observation.
Open attributed record →Albiglutide · 2017-05-03
ClinicalTrials.gov record NCT01777282
Completed at the retained observation.
Open attributed record →